PRME
Prime Medicine·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PRME fundamentals
Prime Medicine (PRME) released its earnings on Nov 7, 2025: revenue was 1.23M (YoY +486.12%), missed estimates; EPS was -0.32 (YoY +27.27%), missed estimates.
Revenue / YoY
1.23M
+486.12%
EPS / YoY
-0.32
+27.27%
Report date
Nov 7, 2025
EPS
Revenue
Revenue & Expenses
PRME has released its 2025 Q3 earnings report, with revenue of 1.23M, reflecting a YoY change of 486.12%, and net profit of -50.58M, showing a YoY change of 3.69%. The Sankey diagram below clearly presents PRME's revenue sources and cost distribution.
Key Indicators
Prime Medicine (PRME) key financial stats and ratios, covering profitability, financial health, and leverage.
Prime Medicine (PRME)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Prime Medicine (PRME)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Prime Medicine (PRME)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Prime Medicine (PRME) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Prime Medicine (PRME) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Prime Medicine's management provide for the next earnings period?What were the key takeaways from Prime Medicine’s earnings call?Did Prime Medicine beat or miss consensus estimates last quarter?What is Prime Medicine's latest dividend and current dividend yield?What is the market's earnings forecast for Prime Medicine next quarter?What were the key takeaways from Prime Medicine's earnings call?What is Prime Medicine's gross profit margin?What factors drove the changes in Prime Medicine's revenue and profit?
